当前位置: 首页 > 期刊 > 《中国当代医药》 > 2018年第1期
编号:13248709
再生障碍性贫血感染危险因素分析(4)
http://www.100md.com 2018年1月5日 《中国当代医药》 2018年第1期
     [15]Quillen K,Wong E,Scheinberg P,et al.Granulocyte transfusions in severe aplastic anemia:an eleven-year experience[J].Haematologica,2009,94(12):1661-1668.

    [16]Wang H,Wu Y,Fu R,et al.Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia:a single center experience from China[J].PLoS One,2014,9(2):e88148.

    [17]Hochsmann B,Moicean A,Risitano A,et al.Supportive care in severe and very severe aplastic anemia[J].Bone Marrow Transplant,2013,48(2):168-173.

    [18]陶丽菊,陈诗强,王小超.再生障碍性贫血医院感染特点及危险因素分析[J].中华医院感染学杂志,2010,20(3):342-344.

    [19]陶晓虹,董红华.再生障碍性贫血患者医院感染相关因素分析与预防[J].中华医院感染学杂志,2016,26(5):1020-1021,1030.

    [20]Phillips R,Hancock B,Graham J,et al.Prevention and management of neutropenic sepsis in patients with cancer: summary of NICE guidance[J].BMJ,2012,345:e5368.

    [21]Torres HA,Bodey GP,Rolston KV,et al.Infections in patients with aplastic anemia:experience at a tertiary care cancer center[J].Cancer,2003,98(1):86-93.

    (收稿日期:2017-08-31 本文編辑:许俊琴), 百拇医药(何虹秀 李琴 李晓明)
上一页1 2 3 4